Physician profile
John J Huang
NPI 1689613747
$5,154.98
in general payments reported to CMS, 2019-2025
33 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $660 · 2021: $286 · 2022: $477 · 2023: $986 · 2024: $915 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,188 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,187.99 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $786.65 | 2019-2025 | Nucala |
| Genzyme Corporation | $688.49 | 2022-2025 | |
| Intersect Ent, INC. | $669.95 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $521.07 | 2019-2025 | Dupixent |
| Optinose US, INC. | $298.42 | 2019-2025 | |
| Kaleo, INC. | $237.85 | 2022-2024 | Auvi-Q |
| Novartis Pharmaceuticals Corporation | $229.66 | 2019-2024 | |
| Stryker Corporation | $178.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $166.14 | 2019-2023 | Fasenra, Tezspire |
| Medtronic, INC. | $159.05 | 2024-2025 | Pteye Parathyroid Detection System, Propel, Stealthstation S8 Platform |
| Sanofi-Aventis U.S. LLC | $153.55 | 2019 | |
| Medtronic USA, INC. | $137.60 | 2020 | |
| Amgen INC. | $97.48 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $92.13 | 2023-2024 | Xembify |
| Celgene Corporation | $91.06 | 2025 | Zeposia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $85.08 | 2022-2023 | Cuvitru |
| Genentech USA, INC. | $77.60 | 2022-2024 | Xolair |
| Ars Pharmaceuticals Operations, INC. | $72.18 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $72.00 | 2023-2024 | Inspire |
| Hikma Pharmaceuticals USA | $40.08 | 2023-2025 | Ryaltris |
| Alk-Abello, INC | $39.46 | 2019-2020 | |
| Csl Behring | $34.10 | 2019-2025 | Andembry |
| Aerin Medical INC. | $29.50 | 2024 | |
| Integra Lifesciences Corporation | $29.32 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Pfizer INC. | $26.01 | 2020 | |
| Blueprint Medicines Corporation | $24.16 | 2023 | Ayvakit |
| Aimmune Therapeutics, INC. | $22.34 | 2020 | |
| Acclarent, INC | $18.57 | 2020 | |
| Allergan, INC. | $17.04 | 2020 | |
| Hologic Sales and Service, LLC | $16.35 | 2024 | Coolseal Generator |
| Amneal Pharmaceuticals LLC | $14.78 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.76 | 2025 | Xhance |
| Phathom Pharmaceuticals, INC. | $14.01 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.